Open AccessDofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation
Author(s) -
Yana Shamiss,
Yaariv Khaykin,
Richard Oosthuizen,
Denise Tunney,
Bradley Sarak,
Marianne Beardsall,
Catherine Seabrook,
Linda Frost,
Zaev Wulffhart,
Bernice Tsang,
Atul Verma
Publication year - 2009
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eup293
Subject(s) - dofetilide , medicine , atrial fibrillation , ablation , refractory (planetary science) , amiodarone , cardiology , catheter ablation , anesthesia , physics , astrobiology
The aim of this study was to assess the safety and efficacy of dofetilide among patients refractory to other anti-arrhythmic drugs (AADs) and accepted for atrial fibrillation (AF) ablation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom